ResearcherSeoul National UniversityActive in the last 2 years

Jin-Young Jang

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5159731463. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 13

Papers, trials and grants by year

2026: 1 paper

Papers 1

Efficacy of neoadjuvant FOLFIRINOX in resectable pancreatic cancer (NeoFOL-R): study protocol for an international, multicenter, prospective, randomized contro… Last author DOI 10.1186/s12885-026-15639-6 ↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Julian Choi · 1 shared paper, 2026 · strength 0.19
- Paper Efficacy of neoadjuvant FOLFIRINOX in resectable pancreatic cancer (NeoFOL-R): study protocol for an international, mul… DOI 10.1186/s12885-026-15639-6 ↗
Ju Won Kim · 1 shared paper, 2026 · strength 0.19
- Paper Efficacy of neoadjuvant FOLFIRINOX in resectable pancreatic cancer (NeoFOL-R): study protocol for an international, mul… DOI 10.1186/s12885-026-15639-6 ↗
In Woong Han · 1 shared paper, 2026 · strength 0.19
- Paper Efficacy of neoadjuvant FOLFIRINOX in resectable pancreatic cancer (NeoFOL-R): study protocol for an international, mul… DOI 10.1186/s12885-026-15639-6 ↗
Yoo‐Seok Yoon · 1 shared paper, 2026 · strength 0.19
- Paper Efficacy of neoadjuvant FOLFIRINOX in resectable pancreatic cancer (NeoFOL-R): study protocol for an international, mul… DOI 10.1186/s12885-026-15639-6 ↗
Keun Soo Ahn · 1 shared paper, 2026 · strength 0.19
- Paper Efficacy of neoadjuvant FOLFIRINOX in resectable pancreatic cancer (NeoFOL-R): study protocol for an international, mul… DOI 10.1186/s12885-026-15639-6 ↗
Hye‐Sol Jung · 1 shared paper, 2026 · strength 0.19
- Paper Efficacy of neoadjuvant FOLFIRINOX in resectable pancreatic cancer (NeoFOL-R): study protocol for an international, mul… DOI 10.1186/s12885-026-15639-6 ↗
Chang-Sup Lim · 1 shared paper, 2026 · strength 0.19
- Paper Efficacy of neoadjuvant FOLFIRINOX in resectable pancreatic cancer (NeoFOL-R): study protocol for an international, mul… DOI 10.1186/s12885-026-15639-6 ↗
Hyung Il Seo · 1 shared paper, 2026 · strength 0.19
- Paper Efficacy of neoadjuvant FOLFIRINOX in resectable pancreatic cancer (NeoFOL-R): study protocol for an international, mul… DOI 10.1186/s12885-026-15639-6 ↗
Hei‐Cheul Jeung · 1 shared paper, 2026 · strength 0.19
- Paper Efficacy of neoadjuvant FOLFIRINOX in resectable pancreatic cancer (NeoFOL-R): study protocol for an international, mul… DOI 10.1186/s12885-026-15639-6 ↗
Do‐Youn Oh · 1 shared paper, 2026 · strength 0.19
- Paper Efficacy of neoadjuvant FOLFIRINOX in resectable pancreatic cancer (NeoFOL-R): study protocol for an international, mul… DOI 10.1186/s12885-026-15639-6 ↗
Jai Hoon Yoon · 1 shared paper, 2026 · strength 0.19
- Paper Efficacy of neoadjuvant FOLFIRINOX in resectable pancreatic cancer (NeoFOL-R): study protocol for an international, mul… DOI 10.1186/s12885-026-15639-6 ↗
Tae Ho Hong · 1 shared paper, 2026 · strength 0.19
- Paper Efficacy of neoadjuvant FOLFIRINOX in resectable pancreatic cancer (NeoFOL-R): study protocol for an international, mul… DOI 10.1186/s12885-026-15639-6 ↗
Wooil Kwon · 1 shared paper, 2026 · strength 0.19
- Paper Efficacy of neoadjuvant FOLFIRINOX in resectable pancreatic cancer (NeoFOL-R): study protocol for an international, mul… DOI 10.1186/s12885-026-15639-6 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.